Bio-Rad Laboratories (BIO) Other Non-Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Other Non-Current Liabilities for 18 consecutive years, with $198.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 14.62% year-over-year to $198.4 million; the TTM figure through Mar 2026 stood at $198.4 million (up 14.62% YoY), while the FY2025 annual figure was $199.1 million, up 12.36% from the prior year.
• Other Non-Current Liabilities steadied at $198.4 million in Q1 2026 per BIO's latest filing, from $199.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $209.6 million in Q2 2025 and bottomed at $173.1 million in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $193.5 million across 5 years, with a median of $195.9 million in 2022.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities dropped 21.31% — and 2026, when it increased 14.62%.
• Bio-Rad Laboratories' Other Non-Current Liabilities stood at $195.9 million in 2022, then dropped by 0.47% to $195.0 million in 2023, then decreased by 9.13% to $177.2 million in 2024, then grew by 12.36% to $199.1 million in 2025, then fell by 0.35% to $198.4 million in 2026.
• Business Quant data shows BIO's Other Non-Current Liabilities at $198.4 million in Q1 2026, $199.1 million in Q4 2025, and $207.5 million in Q3 2025.